BOUNDLESS BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.25 USD | +1.87% |
|
-3.65% | 0.00% |
| 04-22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
| 04-22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Chart calendar Boundless Bio, Inc.
400b8bde.Z5ZvO5aedwWEswQzYq1X1SfT1Q5kBp6OlI61SjsTK_w.KOYlVOP2REi95DdQUJ0tsFXipUgnMq7Fw_rbBnR8caUhzB5x4cEuPbf-MA~b1c059f355af597cb01fc6c658e291f9
Upcoming events on Boundless Bio, Inc.
No events available
Past events on Boundless Bio, Inc.
| 13/05/2024 18:00 | Citizens JMP Life Sciences Conference |
| 13/05/2024 12:00 | Q1 2024 Earnings Release |
| 09/04/2024 21:30 | American Association for Cancer Research Meeting - Poster Number: 14 |
| 08/04/2024 21:30 | American Association for Cancer Research Meeting - Poster Number: 9 |
| 07/04/2024 21:30 | American Association for Cancer Research Meeting - Poster Number: 23 |
Annual results
| Fiscal Period | December | 2023 | 2024 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -72,7 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -77,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -78,3 |
|
Net income Million USD | Released Forecast Spread | -49,4 | -68,1 |
|
EPS USD | Released Forecast Spread | -2,08 | -3,35 |
| Announcement Date | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -16,9 -15,4 -9.51% | -18,3 | -19,5 | -20,3 | -22,8 | -23,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,4 -16,3 5.05% | -18,7 | -21,2 | -23,0 | -21,9 | -23,5 |
|
Net income Million USD | Released Forecast Spread | -15,4 -15,6 1.3% | -16,9 | -18,0 | -18,8 | -21,1 | -22,7 |
|
EPS USD | Released Forecast Spread | -12,3 -0,74 -1569.39% | -0,73 | -0,77 | -0,80 | -0,89 | -1,00 |
| Announcement Date | 13/05/24 | - | - | - | - | - |
More events
Past sector events for Boundless Bio, Inc.
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 15/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 13:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BOLD Stock
- Calendar Boundless Bio, Inc.